Mepacrine Blockade of Arachidonate-lnduced Washed Platelet Aggregation: Relationship to Mepacrine Inhibition of Platelet Cyclooxygenase

Summary

Mepacrine, in addition to its established antilipolytic activity, was also found to inhibit the conversion of ¹⁴C-arachidonic acid to ¹⁴C-thromboxane B₂ in human washed platelets. In the concentration range of 3.33-33 μM, mepacrine exerted a dose dependent inhibition of arachidonate conversion to thromboxane B₂ in parallel to inhibition of arachidonate-induced platelet aggregation. Mepacrine inhibition of thromboxane formation was not accompanied by a concomitant increase in other cyclooxygenase products. Furthermore, mepacrine did not affect platelet transformation of added prostaglandin H₂ to thromboxane A₂ and other products. These results indicate that mepacrine inhibits the cyclooxygenase enzyme and not thromboxane synthase. In washed platelets, mepacrine inhibition of arachidonic acid conversion to thromboxane A₂ appears to be a major factor in the overall inhibitory effect of the compound on the combined process of arachidonate release from cellular phospholipids and its conversion to proaggregatory products.

Keywords

Mepacrine - Platelet aggregation - Arachidonic add - Cyclooxygenase

• References

• 1 Blackwell GJ, Duncombe WG, Flower RJ, Parsons MF, Vane JR. The distribution and metabolism of arachidonic add in rabbit platelets during aggregation and its modification by drugs. Br J Pharmacol 1977; 59: 353-366
• 2 Blackwell GJ, Flower RJ, Nijkamp FP, Vane JR. Phospholipase A₂activity of guinea-pig isolated perfused lungs: stimulation and inhibition by anti-inflammatory steroids. Br J Pharmacol 1978; 62: 79-89
• 3 Hofmann SL, Prescott SM, Majerus PW. The effects of mepacrine and p-Bromophenacyl bromide on arachidonic add release in human platelets. Arch Biochem Biophys 1982; 215: 237-244
• 4 Vargaftig BB, Dao Hai N. Selective inhibition by mepacrine of the release of “rabbit aorta contracting substance” evoked by the administration of bradykinin. J Pharm Pharmacol 1972; 24: 159-161
• 5 Limas C, Limas CJ. The enhanced renomedullary prostaglandin synthesis in spontaneously hypertensive rat: Role of a phospholipase A₂ . Am J Physiol 1979; 236: H65-H72
• 6 Robinson C, Hoult JR. Evidence for functionally distinct pools of phospholipase responsible for prostaglandin release from perfused guinea-pig lung. Eur J Pharmacol 1980; 64: 333-339
• 7 Naor Z, Catt KJ. Mechanism of action of gonadotropin-releasing hormone. Involvement of phospholipid turnover in leutenizing hor-mone release J Biol Chem 1981; 256: 2226-2229
• 8 Hoffman T, Hirata F, Bongnoux P, Fraser BA, Goldfarb RH, Herberman RB, Axelrod J. Phospholipids methylation and phos-pholipase A₂activation in cytotoxidty by human natural killer cells. Proc Natl Acad Sd USA 1981; 78: 3839-3843
• 9 Nijkamp FP, Flower RJ, Moncada S, Vane JR. Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids. Nature 1976; 263: 479-482
• 10 Needleman P, Raz A, Ferrendelli JA, Minkes M. Application of imidiazole as a selective inhibitor of thromboxane synthetase in human platelets. Proc Natl Acad Sd USA 1977; 74: 1716-1720
• 11 Raz A, Schwartzman M, Kenig-Wakshall R. Chemical and enzymatic transformation of prostaglandin endoperoxides: Evidence for the predominance of the 15-hydroperoxy pathway. Eur J Biochem 1976; 70: 89-96
• 12 Gorman RR, Sun FF, Miller OV, Johnson RA. Prostaglandis H₁and H₂ . Convenient biochemical synthesis and isolation Further biological and spectroscopic characterization Prostaglandins 1977; 13: 1043-1053
• 13 Vigo C, Lewis GP, Piper PJ. Mechanisms of inhibition of phospho-lipase A₂ . Biochem Pharmacol 1980; 29: 623-627
• 14 Hornby EJ, Skidmore IF. Evidence that prostaglandin endoperox-ides can induce platelet aggregation in the absence of thromoboxane A₂production. Biochem Pharmacol 1982; 31: 1158-1160
• 15 Volwerk JJ, Pieterson WA, DeHaas GH. Histidine at the active site of phospholipase A₂ . Biochemistry 1974; 13: 1446-1454
• 16 Vargaftig BB, Fouque F, Chignard M. Interference of bromophenacyl bromide with platelet phospholipase A₂activity induced by thrombin and by the ionophore A23187. Thromb Res 1980; 17: 91-102